
The following notice is for health care providers treating a Marshall Protocol patient in an emergency situation.
This patient routinely takes Benicar (Olmesartan medoxomil) 40mg every four hours, as part of a clinical study of antibacterials in chronic inflammatory disease. It is essential to continue this dose and schedule of Benicar, even in the presence of hypotension, as abrupt withdrawal can be life-threatening.
This patient is also taking pulsed antibiotics which may provoke a cytokine storm needing ER intervention. Cytokine storm symptoms may include:
Along with routine lifesaving procedures, it is essential to continue oral Benicar 40mg dosing every four hours, with 20mg SL p.r.n., until symptoms subside - even if an NG tube is necessary.
If B/P is extremely low (mean arterial pressure <55), continue Benicar as above and increase fluid volume with 0.9 NS or packed red cells.
These antibiotics usually cause either an allergic reaction or a cytokine storm:
Flouroquinolone antibiotics are generally well tolerated, although instances of tendon damage have been reported. The patient should be advised of the FDA black-box warnings.
Cephalosporins may be tolerated, Claforin is usually OK.
The macrolide Biaxin is usually OK.
Do not give corticosteroids in any form or by any route (injected, inhaled, oral or IV) as they will lead to metabolic instability.
Adverse reactions may occur if epinephrine or norepinephrine is used to raise B/P or treat anaphylaxis. Use epinephrine and norepinephrine only for cardiac arrest. Local anesthetics containing epinephrine may cause adverse events (tachycardia, psychosis), and the epinephrine may hinder anesthesia.
In an emergency, physicians may call Trevor Marshall at 805-492-3693.
This document is also available as a PDF.
put up ER pdf at autoimmunityresearch.org